Guangzhou LBP Medicine Science & Technology Co Ltd (688393) — Tangible Net Worth Ratio
Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a Tangible Net Worth Ratio of 96.7% as of September 2025. This metric is calculated by deducting intangible assets (CN¥39.63 Million) from net assets (CN¥1.20 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 688393 net asset value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Guangzhou LBP Medicine Science & Technology Co Ltd Tangible Net Worth Ratio (2011–2024)
This chart shows how Guangzhou LBP Medicine Science & Technology Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 96.7%, reflecting net assets of CN¥1.20 Billion with intangible assets of CN¥39.63 Million CNY. Also explore Guangzhou LBP Medicine Science & Technol net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 688393 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.3% | CN¥1.23 Billion | CN¥32.65 Million | CN¥1.36 Billion | ▼ -0.8 pp |
| 2023 | 98.2% | CN¥1.24 Billion | CN¥22.64 Million | CN¥1.40 Billion | ▼ -1.2 pp |
| 2022 | 99.4% | CN¥1.22 Billion | CN¥7.25 Million | CN¥1.39 Billion | ▼ -0.1 pp |
| 2021 | 99.5% | CN¥1.21 Billion | CN¥5.85 Million | CN¥1.37 Billion | ▲ +0.0 pp |
| 2020 | 99.5% | CN¥1.17 Billion | CN¥5.77 Million | CN¥1.29 Billion | ▲ +0.8 pp |
| 2019 | 98.7% | CN¥444.63 Million | CN¥5.92 Million | CN¥537.96 Million | ▲ +0.2 pp |
| 2018 | 98.4% | CN¥389.32 Million | CN¥6.06 Million | CN¥476.56 Million | ▲ +0.3 pp |
| 2017 | 98.1% | CN¥346.28 Million | CN¥6.59 Million | CN¥412.06 Million | ▲ +0.2 pp |
| 2016 | 97.9% | CN¥320.94 Million | CN¥6.88 Million | CN¥357.02 Million | ▼ -2.0 pp |
| 2013 | 99.9% | CN¥215.00 Million | CN¥226.50K | CN¥257.13 Million | ▲ +0.0 pp |
| 2012 | 99.9% | CN¥173.32 Million | CN¥228.20K | CN¥191.92 Million | ▲ +0.1 pp |
| 2011 | 99.8% | CN¥48.09 Million | CN¥114.30K | CN¥111.40 Million | — |